These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33720944)

  • 1. Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.
    Leulseged TW; Hassen IS; Ayele BT; Tsegay YG; Abebe DS; Edo MG; Maru EH; Zewde WC; Naylor LK; Semane DF; Dresse MT; Tezera BB
    PLoS One; 2021; 16(3):e0246087. PubMed ID: 33720944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and outcome profile of hospitalized African patients with COVID-19: The Ethiopian context.
    Leulseged TW; Hassen IS; Maru EH; Zewsde WC; Chamiso NW; Bayisa AB; Abebe DS; Ayele BT; Yegle KT; Edo MG; Gurara EK; Damete DD; Tolera YA
    PLoS One; 2021; 16(11):e0259454. PubMed ID: 34752481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center.
    Leulseged TW; Abebe KG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Bayisa AB; Siyoum DF; Edo MG; Mesfin EG; Derejie MN; Shiferaw HK
    PLoS One; 2022; 17(1):e0262896. PubMed ID: 35085338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients hospitalized with COVID-19.
    Tufa A; Gebremariam TH; Manyazewal T; Asrat Y; Getinet T; Hundie TG; Webb DL; Hellström PM; Genet S
    PLoS One; 2022; 17(10):e0275391. PubMed ID: 36201435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Values of Laboratory Biomarkers in Predicting a Severe Course of COVID-19 on Hospital Admission.
    Tummala A; Ramesh V; Balakrishna N; Koyyada R; Singh AD; Patnam S; Satish Kumar M; Varahala S; Manda SV; Narreddy S
    Biomed Res Int; 2022; 2022():5644956. PubMed ID: 36950250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of death in severe COVID-19 patients at millennium COVID-19 care center in Ethiopia: a case-control study.
    Leulseged TW; Maru EH; Hassen IS; Zewde WC; Chamiso NW; Abebe DS; Jagema TB; Banegyisa AB; Gezahegn MA; Tefera OS; Shiferaw WG; Admasu TT
    Pan Afr Med J; 2021; 38():351. PubMed ID: 34367430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of COVID-19 severity in Ethiopia: a multicentre case-control study.
    Tadie MB; Yimer YS; Taye G
    BMJ Open; 2024 May; 14(5):e083076. PubMed ID: 38803268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haematological Parameters And Outcome In Hospitalized Patients With Covid-19: A Developing Country Experience.
    Iftikhar R; Kamran SM; Mirza ZE; Naseem A; Ali Shah SA; Riaz S; Fazal I; Alamgir W; Saeed F; Saleem S; Ali RS; Chaudhry QUN
    J Ayub Med Coll Abbottabad; 2021; 33(3):416-424. PubMed ID: 34487649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 compared with Influenza and respiratory syncytial virus infection.
    Prozan L; Shusterman E; Ablin J; Mitelpunkt A; Weiss-Meilik A; Adler A; Choshen G; Kehat O
    Sci Rep; 2021 Nov; 11(1):21519. PubMed ID: 34728719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.
    Espiritu AI; Chiu HHC; Sy MCC; Anlacan VMM; ; Jamora RDG
    Sci Rep; 2021 Dec; 11(1):24436. PubMed ID: 34952903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
    Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Poor Treatment Outcome among Hospitalized COVID-19 Patients in South Central, Ethiopia.
    Kaso AW; Hareru HE; Kaso T; Agero G
    Biomed Res Int; 2022; 2022():4551132. PubMed ID: 35252447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predication of oxygen requirement in COVID-19 patients using dynamic change of inflammatory markers: CRP, hypertension, age, neutrophil and lymphocyte (CHANeL).
    Lee EE; Hwang W; Song KH; Jung J; Kang CK; Kim JH; Oh HS; Kang YM; Lee EB; Chin BS; Song W; Kim NJ; Park JK
    Sci Rep; 2021 Jun; 11(1):13026. PubMed ID: 34158545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric correlation of laboratory biomarkers to multiorgan failure outcome in hospitalized COVID-19 patients: a retrospective observational study.
    Ballini A; Cantore S; Serretiello E; Troiano G; Smimmo A; Dioguardi M; Spirito F; Sasso FC; De Vito D; Lo Muzio L; Di Domenico M
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8962-8974. PubMed ID: 37782206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Severe COVID-19 in Children.
    Graff K; Smith C; Silveira L; Jung S; Curran-Hays S; Jarjour J; Carpenter L; Pickard K; Mattiucci M; Fresia J; McFarland EJ; Dominguez SR; Abuogi L
    Pediatr Infect Dis J; 2021 Apr; 40(4):e137-e145. PubMed ID: 33538539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study.
    Leulseged TW; Alemahu DG; Hassen IS; Maru EH; Zewde WC; Chamiso NW; Yegele KT; Abebe DS; Abdi FM; Minyelshewa EY; Gerbi TG; Hagos HT
    BMC Infect Dis; 2021 Aug; 21(1):759. PubMed ID: 34353283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.